platinum has been researched along with Carcinoma, Epidermoid in 111 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (14.41) | 18.7374 |
1990's | 17 (15.32) | 18.2507 |
2000's | 12 (10.81) | 29.6817 |
2010's | 41 (36.94) | 24.3611 |
2020's | 25 (22.52) | 2.80 |
Authors | Studies |
---|---|
Fukuda, N; Hara, Y; Horita, N; Kaneko, A; Kaneko, T; Kobayashi, N; Namkoong, H; Somekawa, K; Tagami, Y; Watanabe, K | 1 |
Dong, X; Jia, Y; Song, X; Song, Y; Wang, W; Yi, Y; Zhang, J | 1 |
Cai, L; Chen, C; Deng, H; Li, S; Lin, X; Liu, M; Qin, Y; Qiu, G; Xie, X; Xie, Z; Yang, Y; Zhou, C | 1 |
Chang, JH; Chang, TH; Chen, WT; Chien, LN; Chou, YT; Chung, CL; Hong, SY; Hsiao, SH; Lin, SE | 1 |
Cui, GH; Deng, YW; Li, SH; Li, YJ; Li, YW; Lu, D | 1 |
Han, SB; He, Y; Liu, Y; Wu, YM; Zhang, JJ | 1 |
Anandappa, G; Arnold, D; Capdevila, J; Catlett, M; Cornfeld, M; Dahan, L; Demols, A; Evesque, L; Fakih, M; Gilbert, DC; Guren, MG; Jensen, LH; Kayyal, T; Kim, S; Rao, S; Samalin, E; Saunders, MP; Smith, M; Spano, JP; Spindler, KL; Tamberi, S; Tian, C | 1 |
Rodriguez, E; Santos, ES | 1 |
Akimoto, T; Daiko, H; Fujita, T; Fujiwara, H; Hojo, H; Ito, R; Kojima, T; Nakamura, N; Nakamura, Y; Sunakawa, H; Yano, T; Yoshino, T | 1 |
Guo, Y; Liu, Y; Xia, Z; Xue, L; Zhang, Q | 1 |
Gibson, MK; Weidenbaum, C | 1 |
Fushimi, C; Hanyu, K; Ito, T; Kondo, T; Masubuchi, T; Matsuki, T; Miura, K; Okada, T; Okamoto, I; Omura, GO; Oridate, N; Sato, H; Tada, Y; Takahashi, H; Tokashiki, K; Tsukahara, K; Yamashita, T | 1 |
Chen, C; Chen, H; Chen, T; Du, W; Fu, S; He, LN; Hong, S; Lin, Z; Zhang, X; Zhou, Y | 1 |
Biancalana, L; Ermini, ML; Frusca, V; Giannini, N; Gonnelli, A; Mapanao, AK; Marchetti, F; Santi, M; Sarogni, P; Voliani, V; Zamborlin, A | 1 |
Biswas, S; Ghosh, B; Itoo, AM; Paul, M | 1 |
Hao, Y; Jin, J; Si, J; Song, Z; Wei, J; Xiang, J; Xu, C | 1 |
Acharya, R; Anderson, JL; Delgoffe, GM; Ferris, RL; Harris, AL; Hsieh, RW; Li, J; Menk, AV; Nilsen, ML; Scheff, NN; Swartz, A; Zandberg, DP | 1 |
Argiris, A; Bratland, Å; Chung, CH; Coutte, A; de Azevedo, S; Even, C; Fayette, J; Ferris, RL; Gillison, M; Grant, C; Grell, P; Haddad, R; Hansen, AR; Harrington, KJ; Khan, TA; Miller-Moslin, K; Redman, R; Roberts, M; Salas, S; Schenker, M; Soulières, D; Tahara, M; Walker, JWT; Wei, L | 1 |
Chen, WW; Chu, XY; Huang, QC; Lu, L; Sun, Q; Wang, JH; Wang, R; Wang, T | 1 |
Edwards, A; Falk, S; Hackshaw, A; Hatton, M; Jones, R; Lal, R; Lee, SM; Lewanski, C; Ngai, Y; Rudd, R; Skailes, G; Toy, E; Upadhyay, S; Woll, PJ | 1 |
Hamburger, T; Kadouri, L; Lipson, D; Nechushtan, H; Peretz, T; Rottenberg, Y; Zick, A | 1 |
Bradford, DS; Crane, J; Deal, AM; Irvin, W; Lee, C; Morgensztern, D; Muss, HB; Pecot, C; Pennell, N; Socinski, M; Stevenson, JP; Stinchcombe, T; Villaruz, LC; Weiss, JM; West, HJ | 1 |
Gupte-Singh, K; Le, TK; Lubinga, SJ; Penrod, JR; Smith, CB; Stenehjem, DD; Zhang, Y | 1 |
Kato, S; Miwa, N; Saitoh, Y | 1 |
Abakumov, MA; Abdul Razak, IB; Aisa, HA; Akhmirov, RT; Aladinskaya, AV; Allem, JP; Allu, SR; Ambale-Venkatesh, B; Anasori, B; Arizcorreta, A; Armentrout, PB; Baumann, H; Beloglazkina, EK; Ben-Elyiahu, Y; Ber, AP; Berthon, C; Bettelheim, A; Bluemke, DA; Bonsignore, M; Bordet, A; Borruso, A; Boxer, MB; Bress, AP; Brimacombe, KR; Brown, DE; Brüggemann, M; Cafeo, A; Cao, K; Cao, L; Carnicelli, J; Carr, JC; Cavallo, L; Cazin, CSJ; Cheff, DM; Chen, G; Chen, H; Chen, J; Chen, R; Chen-Sankey, JC; Cheng, C; Cheng, Y; Cheruku, RR; Chida, N; Choi, K; Chu, M; Cipolli, M; Colantonio, LD; Collado, A; Cook, J; Cordes, DB; Covey, J; Cuesta-Sancho, S; Davis, MI; Demireva, M; Derington, CG; Di Rosa, G; Dicanio, D; Dong, G; Dontsova, OA; Dormanesh, A; Dovrat, G; Duan, XM; Duarte, DA; Efthymiou, S; Erofeev, AS; Falivene, L; Fang, Y; Feng, D; Fernandes, VRS; Finko, AV; Freitag, TM; Frye, S; Gachot, C; Gao, S; Garanina, AS; Getya, D; Girón-González, JA; Girón-Ortega, JA; Gitsov, I; Gorelkin, PV; Grützmacher, PG; Guo, PY; Gutiérrez-Saborido, D; Habibi, M; Hall, MD; Hayes-Ryan, D; He, ZZ; Henderson, MJ; Herrick, JS; Herrmann, H; Hoang, Y; Hofmann, W; Hollingshead, M; Houlden, H; Hu, L; Huang, B; Huang, Y; Hussain, M; Huynh, HP; Iansa, P; Ivanenkov, YA; Jadhav, A; Jalaludin, B; Jalava, P; Karavadhi, S; Karpasas, M; Katahara, S; Kawel-Boehm, N; Khazanova, ES; King, JB; Klumpp-Thomas, C; Knibbs, LD; Komiya, Y; Komppula, M; Kranidiotis-Hisatomi, N; Krasnovskaya, OO; Kwiezinski, C; Lee, SW; Lee, TD; Leitner, W; Lerner, A; Leskinen, A; Li, B; Li, J; Li, Y; Li, Z; Liang, D; Liao, HB; Lima, JAC; Lin, L; Lin, W; Lin, Z; Liu, H; Liu, K; Liu, L; Liu, Q; Liu, Y; Lu, K; Luo, M; Ma, B; Machulkin, AE; Maimon, E; Majouga, AG; Márquez-Coello, M; Martinez, NJ; McCarthy, C; McIver, A; Meaney, S; Melotti, P; Menin, L; Mertes, S; Michael, S; Missert, JR; Moisy, P; Monda, KL; Mondello, P; Moore, WJ; Mücklich, F; Mues, KE; Muntner, P; Nahra, F; Navar, AM; Nelson, DJ; Nelson, RE; Ni, S; Nicotera, AG; Nimenko, EA; Nolan, SP; O'Donoghue, K; Oestreich, M; Pandey, RK; Pang, RD; Patnaik, S; Pei, W; Petrov, SA; Pevzner, S; Phillips, KS; Pintani, E; Pironti, E; Pokrovsky, VS; Polshakov, VI; Poudel, B; Pragani, R; Presser, V; Qu, H; Rahsepar, AA; Ramsey, MW; Ravotto, L; Ren, D; Ren, G; Ren, L; Rogach, AL; Rohde, JM; Roponen, M; Rosen, BD; Rosenkranz, A; Rosenson, RS; Salpietro, V; Saltykova, IV; Sato, T; Saveliev, OY; Senger, AR; Shafikov, RR; Shataer, D; Shen, M; Shi, Y; Shu, X; Simeonov, A; Skvortsov, DA; Slawin, AMZ; Smirnova, GB; Song, G; Stevens, VW; Stott, GM; Stratmann, F; Su, BJ; Suarez, S; Sugiyama, Y; Tabaczynski, W; Teo, KL; Tolosa, A; Totorika, A; Tracy, EC; Treggiari, D; Tridello, G; Troxler, T; Urban, DJ; Uspenskaya, AA; Vainer, R; Van Hecke, K; van Pinxteren, D; Vanden Broeck, SMP; Vanneman, ME; Vinogradov, SA; Wang, B; Wang, H; Wang, HS; Wang, L; Wang, R; Wang, X; Wang, YQ; Weller, C; Winkler-Heil, R; Xia, F; Xiao, F; Xin, XL; Xing, H; Xu, J; Xu, SL; Xu, Z; Yamane, M; Yamansarov, EU; Yan, T; Yang, BY; Yang, G; Yang, L; Yang, P; Yang, X; Yao, T; Yasgar, A; Ye, N; Yi, H; Yin, C; Yu, DYW; Yu, HY; Yu, J; Yuan, M; Zagefka, H; Zeng, XW; Zhang, H; Zhang, S; Zhang, W; Zhao, D; Zhao, W; Zhao, X; Zheng, H; Zheng, YK; Zhu, X; Zilbermann, I; Zyk, NU; Zyk, NV | 1 |
Feng, Y; Jiang, W; Kang, Y; Li, G; Li, J; Ma, H; Yu, X; Zhang, C | 1 |
Cang, S; Chen, G; Cui, J; Du, Y; Fan, M; Fan, Y; Fang, J; Hu, C; Huang, D; Li, B; Li, J; Li, Y; Liu, L; Sun, P; Wang, S; Wang, Z; Wu, L; Xue, J; Yang, Z; Zhang, L; Zhang, W; Zhao, H; Zhou, C; Zhou, H; Zhou, J | 1 |
Fujimoto, E; Okame, S; Okazawa-Sakai, M; Shiroyama, Y; Takehara, K; Yokoyama, T | 1 |
Chen, X; Cheng, R; Chu, HY; Jiang, YE; Qi, X; Sun, CZ; Wang, W; Zeng, MS; Zhong, ZM; Zhu, XF | 1 |
Cai, Y; Han, W; Kang, A; Song, C; Wang, Y; Wang, Z; Wei, Z; Xu, W; Yin, X; Zhang, J | 1 |
Si, X; Wang, H; Wang, M; Wu, S; Zeng, X; Zhang, L; Zhang, X | 1 |
Ariyoshi, W; Enomoto, Y; Iwanaga, K; Matsumura, Y; Matsuo, K; Nishihara, T; Okinaga, T; Sasaguri, M; Tanaka, M; Tominaga, K; Toyono, T | 1 |
Tahara, M | 1 |
de Castria, TB; Fujiki, FK; Hoff, PMG; Takeda, FR; Victor, CR | 1 |
Braakhuis, BJ; Brakenhoff, RH; Brink, A; Dalm, SU; Honeywell, RJ; Martens-de Kemp, SR; Peters, GJ; Wijnolts, FM | 1 |
Cai, Y; Chen, H; Gao, Z; Han, B; Jiang, G; Li, X; Lu, D; Qian, J; Su, B; Tan, X; Wang, J; Wang, S; Wu, Q; Yang, Y; Zhao, X | 1 |
Chan, C; Colevas, AD; Jiang, W; Kong, C; Le, QT; Lee-Enriquez, N; Murphy, JD; Pinto, H; Tang, C; von Eyben, R | 1 |
Alves, MP; Avezedo, I; de Mello, RA; Dinis, J; Gerós, S; Moreira, F | 1 |
Cohen, EE; Haddad, RI; Licitra, LF; Machiels, JP; Tahara, M | 1 |
Alakus, H; Bollschweiler, E; Drebber, U; Eberz, PM; Frazer, KA; Harismendy, O; Hölscher, AH; Lowy, AM; Maus, M; Metzger, R; Mönig, SP; Siffert, W; Warnecke-Eberz, U | 1 |
Georgoulias, V; Giagkas, G; Ioannidis, G; Koutsopoulos, A; Lagoudaki, E; Mavroudis, D; Papadaki, C; Sfakianaki, M; Souglakos, J; Trypaki, M; Tsakalaki, E; Voutsina, A | 1 |
Hamaguchi, T; Honma, Y; Iwasa, S; Kato, K; Nagashima, K; Nishikawa, A; Okita, N; Sasaki, Y; Sawada, R; Shimada, Y; Shirakawa, T; Shoji, H; Takahashi, N; Takashima, A; Yamada, Y | 1 |
Fukuda, S; Furusawa, J; Hatakeyama, H; Homma, A; Iizuka, S; Kano, S; Mizumachi, T; Onimaru, R; Sakashita, T; Shirato, H; Tsuchiya, K; Yasuda, K | 1 |
Maeda, A; Nakata, M; Nojima, Y; Okita, R; Saisho, S; Shimizu, K; Yukawa, T | 1 |
Caponigro, F; Clement, PM; Cohen, EE; Cong, XJ; Cupissol, D; de Castro, G; de Souza Viana, L; Del Campo, JM; Ehrnrooth, E; Fayette, J; Gauler, T; Grau, JJ; Guigay, J; Haddad, RI; Keilholz, U; Licitra, LF; Machiels, JP; Tahara, M; Vermorken, JB | 2 |
Bail, JP; Brigand, C; Collet, D; Gronnier, C; Lebreton, G; Luc, G; Mabrut, JY; Mariette, C; Meunier, B | 1 |
Blumenschein, GR; Canales, JR; Ginsberg, LE; Heymach, JV; Kies, MS; Lee, JJ; Lin, H; Lu, C; Massarelli, E; Papadimitrakopoulou, V; Tran, HT; Williams, MD | 1 |
Hassan, U; Mozayani, B; Wong, NA | 1 |
Adkins, D; Aguilar, JL; Bryant, K; Chang, SC; Chen, E; Chin, S; Ernst, S; He, S; Lee, HJ; Misiukiewicz, K; Obasaju, CK; Soulières, D | 1 |
Guancial, E; Iczkowski, KA; Kilari, D; Kim, ES; Messing, EM; Pandya, C; Robin, AJ | 1 |
Binder, M; Bokemeyer, C; Braig, F; Busch, CJ; Grob, T; Knecht, R; Kriegs, M; Laban, S; Schieferdecker, A; Voigtlaender, M | 1 |
Cheng, L; Jia, M; Qiu, L; Wang, M; Wei, Q; Xiang, J; Zhou, F; Zhu, M | 1 |
Cohen, C; Hanley, KZ; Horowitz, IR; Khanna, N; Rubinsak, LA | 1 |
Berghmans, T; Biesma, B; Chittazhathu Kurian Kuruvilla, Y; Ciardiello, F; Coate, L; Cobo Dols, M; Collado Martin, R; Cuffe, S; Curioni-Fontecedro, A; Dafni, U; de Hosson, S; Garde Noguera, J; Gasca-Ruchti, A; Gautschi, O; Gregorc, V; Groen, HJM; Horgan, A; Insa, A; Juan Vidal, Ó; Kassapian, M; Láng, I; López Martín, A; Mark, MT; Massutí, B; Meldgaard, P; Novello, S; Palmero Sanchez, R; Peralta, S; Peters, S; Pieterman, R; Ponce Aix, S; Rauch, D; Smit, EF; Stahel, RA; Summers, Y; Torri, V; Tsourti, Z; van den Berg, PM; van Heemst, R; van Henten, AMJ; Villa Guzmán, JC; Zielinski, CC | 1 |
Aimone, P; Alyasova, A; Barone, C; Chakravartty, A; Chol, M; Dechaphunkul, A; Erfán, J; Faivre, S; Hirawat, S; Karpenko, A; Kasper, S; Kim, SB; Kiss, LA; Li, SH; Licitra, L; Lin, JC; Mesía, R; Nagarkar, R; Ochsenreither, S; Remenár, É; Soulières, D; Tamás, L; Turri, S | 1 |
Jeremić, B; Milicić, B | 1 |
Enomoto, T; Fukutsuji, K; Ikeda, H; Kitano, H; Morizane, R; Nakahara, K; Nosaka, A; Sakoda, T; Shibano, A; Yamanishi, M | 1 |
Ciuleanu, T; Darstein, CL; Latz, JE; Musib, LC; Specenier, PM; Vermorken, JB | 1 |
Cho, JH; Jang, TW; Kim, CS; Kim, HJ; Kim, HT; Kim, SK; Kim, YH; Kwak, SM; Lee, JE; Ryu, JS; Shin, ES; Yoo, YK; Yun, MH | 1 |
Crysandt, M; Esser, A; Jost, E; Osieka, R; von Hobe, S; Wilop, S | 1 |
Chun, KC; Kim, DY; Kim, JH; Kim, YM; Kim, YT; Nam, JH | 1 |
Benasso, M; Erfán, J; Hitt, R; Kawecki, A; Licitra, L; Mesia, R; Remenár, É; Rivera, F; Rottey, S; Senger, S; Störkel, S; Stroh, C; Vermorken, JB; Zabolotnyy, D | 1 |
Eguchi, K; Ichinose, Y; Kishi, K; Minato, K; Nishikawa, M; Nogami, N; Okamoto, H; Seki, N; Seto, T; Shinkai, T; Takiguchi, Y; Watanabe, K | 1 |
Berard, H; Bota, S; Chouaid, C; Corre, R; Crequit, J; Dujon, C; Paillotin, D; Robinet, G; Thomas, P; Vergnenegre, A | 1 |
Argiris, A; Ballas, MS; Belani, CP; Davies, A; Edelman, M; Gandara, DR; Gitlitz, BJ; Groshen, S; Hoffman, P; Koczywas, M; Liu, SV; Ramalingam, S; Tsao-Wei, DD; Vokes, EE | 1 |
Burhenne, J; Detering, JC; Dyckhoff, G; Haefeli, WE; Herold-Mende, C; Theile, D; Weiss, J | 1 |
Cohen, J; Halm, EA; Mandeli, J; Mhango, G; Sigel, K; Strauss, G; Wisnivesky, J | 1 |
Duan, Z; He, C; Li, P; Xu, Q; Yuan, Y | 1 |
Correa, AM; Erasmus, JJ; Gold, KA; Heymach, J; Kalhor, N; Kim, ES; Lee, JJ; Munden, R; Papadimitrakopoulou, V; Pataer, A; Rice, DC; Swisher, SG; William, WN; Wistuba, II | 1 |
Arias-Pulido, H; Bauman, JE; Bishop, J; Chung, CH; Fekrazad, MH; Fertig, E; Howard, J; Jones, DV; Lee, SJ; Olson, GT; Ozawa, H; Spafford, MJ; Wang, H | 1 |
Ito, K; Nagase, S; Nemoto, K; Niikura, H; Ogawa, Y; Takano, T; Yaegashi, N; Yoshinaga, K | 1 |
Boku, N; Ebihara, M; Iida, Y; Onitsuka, T; Onozawa, Y; Zenda, S | 1 |
Cannon, M; Cmelak, AJ; Forastiere, AA; Gillison, M; Goldwasser, MA; Li, S; Murphy, B; Pinto, H; Rosenthal, DI | 1 |
Ervin, TJ; Fabian, RL; Miller, D; Norris, CM; Posner, MR; Rose, C; Weichselbaum, RR | 1 |
Kuhn, JG; Mattox, DE; Repta, AJ; Sternson, LA; Von Hoff, DD | 1 |
Gall, HE; Klein, I; Pinedo, HM; van der Vijgh, WJ; Vermorken, JB | 1 |
Fujii, M; Horiuchi, M; Inuyama, Y; Kohno, N; Mashino, S | 1 |
Henkel, H; Nagel, GA; von Heyden, HW; Weinstock, N | 1 |
Asfaw, I; Buroker, T; Dindogru, A; Franklin, R; Hoschner, D; Knechtges, T; Leichman, L; Loh, JJ; Miller, P; Pietruk, T; Rosenberg, JC; Seydel, H; Steiger, Z; Torres, A; Vaishamapayan, G; Vaitkevicius, V; Wilson, RF | 1 |
Bernard, JP; Fournel, P; Jorda, M; Laennec, E; Piperno, D; Rebattu, P; Souquet, PJ; Trillet, V | 1 |
Asanami, S; Susami, E; Uchiyama, K | 1 |
Murakami, T; Nagai, N; Ohama, K | 1 |
Hamada, M; Kohso, T; Shimamoto, T; Tateyama, H | 1 |
Aggarwal, SK; Gemma, NW; Herold, DA; Kinter, M; Nicholson, J; Shipe, JR | 1 |
Cavallin-Stahl, E; Johnsson, A | 1 |
Hayashi, N; Ikeba, K; Kinoshita, K; Ohokubo, T; Sodemoto, T; Takagi, A; Takeda, S; Yamamoto, T | 1 |
Bakker, PJ; Blommaert, FA; Geerdink, A; Haveman, J; Rietbroek, RC; van de Vaart, PJ; Veenhof, CH | 1 |
Baan, RA; Braakhuis, BJ; Cloos, J; Fichtinger-Schepman, AM; Hermsen, MA; van der Vijgh, WJ; Welters, MJ | 1 |
Harada, N; Hori, Y; Kawamoto, K; Kumazawa, H; Sai, S; Tachikawa, T; Yamashita, T; Yodosawa, S | 1 |
Braakhuis, BJ; Cloos, J; Fichtinger-Schepman, AM; Pankras, JE; Smeets, SJ; Welters, MJ | 1 |
Brès, J; Constans, B; Cupissol, D; Gau, F; Gory-Delabaere, G; Nouguier-Soulé, J | 1 |
Areberg, J; Johnsson, A; Mattsson, S; Norrgren, K; Wennerberg, J | 1 |
Hamana, S; Ku, Y; Maruo, T; Miyahara, Y; Motoyama, S; Takeuchi, S; Tateiwa, Y; Yoshida, S | 1 |
Kumada, K; Makuuchi, M; Midorikawa, T; Nemoto, H; Sanada, Y; Sasaya, S; Takeuchi, S; Takizawa, K; Uemichi, O; Yamaguchi, M; Yoshizawa, Y | 1 |
Brasnu, D; Hans, S; Laccourreye, H; Laccourreye, O; Ménard, M; Veivers, D | 1 |
Carr, DT; Coles, DT; Eagan, RT; Frytak, S; Ingle, JN; Kvols, LK; O'Fallon, JR; Rubin, J | 1 |
Holding, JD; Lindup, WE; Schilling, V; Stell, PM; van Laer, C; Vreeburg, GC; Wilson, JA | 1 |
Akita, H; Fijita, H; Haneda, H; Katabami, M; Kawakami, Y; Kuzumaki, N; Miyamoto, H | 1 |
Francois, E; Frenay, M; Milano, G; Namer, M; Troger, V | 1 |
Brann, TW; Frei, E; Herman, TS; Holden, SA; Khandekar, V; Korbut, TT; Rosbe, KW; Sotomayor, EA; Teicher, BA | 1 |
Bowdler, DA; Holding, JD; Lindup, WE; Siodlak, MZ; Stell, PM | 1 |
Breau, JL; Clavier, J; Gres, JJ; Israël, L; Lerebours-Pigeonnière, G; Morère, JF; Nouvet, G; Raut, Y; Zabbe, C | 1 |
Ebihara, T; Fukushima, M; Kawakami, S; Maruyama, K; Sawada, T; Tateyama, Y; Yoshimura, Y | 1 |
Herman, TS; Teicher, BA; Wang, Y | 1 |
Hayashibara, K; Hirosawa, A; Niitani, H; Tsuboi, E | 1 |
Atkinson, N; Castellanos, AM; Choksi, AJ; Dimery, IW; Felder, TB; Hong, WK; McCarthy, K; Newman, RA; Paredes, J; Robbins, KT | 1 |
Delobelle, A; Demaille, MC; Fournier, C; Hecquet, B; Lequint, A; Poissonnier, B; Vennin, P | 1 |
Abad-Esteve, A; Fernandez, C; Monras, P; Moreno, I; Morera, J; Ribas-Mundo, M; Rosell, R; Ruiz, J | 1 |
Abrams, MJ; Holden, SA; Jacobs, JL; Jones, AG; Teicher, BA | 1 |
Cucchi, CA; Frei, E; Henner, WD; Holden, SA; Kelley, MJ; Rosowsky, A; Shea, TC; Teicher, BA | 1 |
4 review(s) available for platinum and Carcinoma, Epidermoid
Article | Year |
---|---|
Best regimens for treating chemo-naïve incurable squamous non-small cell lung cancer with a programmed death-ligand 1 tumor proportion score of 1%-49%: A network meta-analysis.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Humans; Immune Checkpoint Inhibitors; Ipilimumab; Lung Neoplasms; Nivolumab; Platinum; Progression-Free Survival; Randomized Controlled Trials as Topic | 2022 |
Treatment Considerations for Patients With Advanced Squamous Cell Carcinoma of the Lung.
Topics: Afatinib; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Docetaxel; Humans; Lung; Lung Neoplasms; Platinum | 2022 |
Approach to Localized Squamous Cell Cancer of the Esophagus.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Epithelial Cells; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Paclitaxel; Platinum; Quality of Life | 2022 |
Intracellular calcium changes and chemosensitivities of human epidermoid carcinoma cell lines after exposure to cisplatin.
Topics: Antineoplastic Agents; Calcium; Carcinoma, Squamous Cell; Chemoreceptor Cells; Cisplatin; Humans; KB Cells; Nasopharyngeal Neoplasms; Platinum; Tumor Cells, Cultured | 1998 |
32 trial(s) available for platinum and Carcinoma, Epidermoid
Article | Year |
---|---|
A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202).
Topics: Anal Canal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Anus Neoplasms; Carcinoma, Squamous Cell; Humans; Immune Checkpoint Inhibitors; Platinum | 2022 |
The clinical role of VeriStrat testing in patients with advanced non-small cell lung cancer considered unfit for first-line platinum-based chemotherapy.
Topics: Adenocarcinoma of Lung; Aged; Aged, 80 and over; Biomarkers, Tumor; Blood Proteins; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Double-Blind Method; Erlotinib Hydrochloride; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Platinum; Predictive Value of Tests; Protein Kinase Inhibitors; Proteomics; Survival Rate | 2019 |
Nab-paclitaxel in older patients with non-small cell lung cancer who have developed disease progression after platinum-based doublet chemotherapy.
Topics: Adenocarcinoma of Lung; Aged; Aged, 80 and over; Albumins; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Paclitaxel; Platinum; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate | 2020 |
Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12).
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Deoxycytidine; Double-Blind Method; Gemcitabine; Humans; Lung Neoplasms; Platinum | 2021 |
Rationale and design of LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy.
Topics: Afatinib; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Clinical Protocols; Disease Progression; Head and Neck Neoplasms; Humans; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Quinazolines; Retreatment; Squamous Cell Carcinoma of Head and Neck | 2014 |
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.
Topics: Adult; Afatinib; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Quinazolines; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2015 |
Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinoma.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Resistance, Neoplasm; Erlotinib Hydrochloride; Everolimus; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Platinum; Prognosis; Salvage Therapy; Survival Rate | 2015 |
Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a randomized, double-blind safety study comparing cetuximab produced from two manufacturing processes using the EXTREME study regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Chemistry, Pharmaceutical; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Platinum; Squamous Cell Carcinoma of Head and Neck | 2016 |
Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial.
Topics: Afatinib; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Quinazolines; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2016 |
Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non-Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic On
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cohort Studies; Docetaxel; Erlotinib Hydrochloride; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Neoplasm Staging; Platinum; Prognosis; Survival Rate; Taxoids | 2017 |
Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial.
Topics: Adult; Aged; Aged, 80 and over; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Double-Blind Method; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; International Agencies; Male; Middle Aged; Morpholines; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Platinum; Prognosis; Survival Rate | 2017 |
Pretreatment prognostic factors of local recurrence-free survival in locally advanced squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapy.
Topics: Aged; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Disease-Free Survival; Dose Fractionation, Radiation; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Platinum; Prognosis; Radiation Dosage | 2008 |
[Docetaxel (TXT) and irinotecan (CPT-11) as a second-line chemotherapy for platinum-pretreated squamous cell carcinoma of the head and neck].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Squamous Cell; Docetaxel; Dose-Response Relationship, Drug; Female; Head and Neck Neoplasms; Humans; Irinotecan; Male; Middle Aged; Platinum; Taxoids | 2008 |
Pharmacokinetic evaluation of platinum derived from cisplatin administered alone and with pemetrexed in head and neck cancer patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma, Squamous Cell; Cisplatin; Cross-Over Studies; Dietary Supplements; Female; Glutamates; Guanine; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Pemetrexed; Platinum; Prognosis; Treatment Outcome | 2009 |
Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cetuximab; ErbB Receptors; Fluorouracil; Gene Dosage; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Survival Analysis; Treatment Outcome; Young Adult | 2011 |
Long-term administration of second-line chemotherapy with S-1 and gemcitabine for platinum-resistant non-small cell lung cancer: a phase II study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Deoxycytidine; Drug Combinations; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Oxonic Acid; Platinum; Salvage Therapy; Survival Rate; Tegafur; Time Factors; Treatment Outcome | 2011 |
Cost-effectiveness of second-line chemotherapy for non-small cell lung cancer: an economic, randomized, prospective, multicenter phase III trial comparing docetaxel and pemetrexed: the GFPC 05-06 study.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Docetaxel; Female; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pemetrexed; Platinum; Prospective Studies; Salvage Therapy; Survival Rate; Taxoids; Treatment Outcome | 2011 |
A phase II study of halichondrin B analog eribulin mesylate (E7389) in patients with advanced non-small cell lung cancer previously treated with a taxane: a California cancer consortium trial.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Ethers, Cyclic; Female; Follow-Up Studies; Furans; Humans; Ketones; Lung Neoplasms; Macrolides; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Platinum; Salvage Therapy; Survival Rate; Taxoids; Treatment Outcome | 2012 |
Role of ERCC5 promoter polymorphisms in response to platinum-based chemotherapy in patients with advanced non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Confidence Intervals; DNA-Binding Proteins; Endonucleases; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nuclear Proteins; Platinum; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Transcription Factors; Transcription Initiation Site; Treatment Outcome; Young Adult | 2013 |
A phase II study of temsirolimus and erlotinib in patients with recurrent and/or metastatic, platinum-refractory head and neck squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Class I Phosphatidylinositol 3-Kinases; Cyclin-Dependent Kinase Inhibitor p16; Cytokines; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mutation; Neoplasm Recurrence, Local; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Platinum; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); PTEN Phosphohydrolase; Quinazolines; Ribosomal Protein S6 Kinases; Sirolimus; Survival Rate; TOR Serine-Threonine Kinases; Tumor Suppressor Proteins | 2013 |
Phase I trial of concurrent chemoradiation with weekly nedaplatin in patients with squamous cell carcinoma of the uterine cervix.
Topics: Adult; Aged; Antineoplastic Agents; Brachytherapy; Carcinoma, Squamous Cell; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Organoplatinum Compounds; Platinum; Radioisotope Teletherapy; Uterine Cervical Neoplasms | 2007 |
Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Deglutition Disorders; Female; Follow-Up Studies; Humans; Laryngeal Neoplasms; Laryngectomy; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Pharyngectomy; Platinum; Radiotherapy, Adjuvant; Recovery of Function; Salvage Therapy; Speech Disorders; Taxoids; Treatment Outcome | 2007 |
[Results of a combination of platinum-vindesin-ametycin-bleomycin (CEMB) in the treatment of stage IV non-small-cell lung cancers].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Platinum; Vindesine | 1993 |
Neoadjuvant chemotherapy using a platinum, vincristine and peplomycin (CVP) combination in patients with carcinoma of the uterine cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Humans; Middle Aged; Peplomycin; Platinum; Survival Rate; Uterine Cervical Neoplasms; Vincristine | 1993 |
[Clinical effect of intra-arterial carboplatin-combined chemotherapy for advanced uterine cervical cancer and increased tissue platinum levels with Lipo PGE1 administration before chemotherapy].
Topics: Adenocarcinoma; Adult; Aged; Alprostadil; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cervix Uteri; Chemotherapy, Adjuvant; Epirubicin; Etoposide; Female; Humans; Iliac Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Middle Aged; Mitomycin; Platinum; Uterine Cervical Neoplasms; Vindesine | 1996 |
Super high-dose intraarterial cisplatin infusion under percutaneous pelvic perfusion with extracorporeal chemofiltration for advanced uterine cervical carcinoma: I. Analysis for pharmacokinetics, tumor response, and toxicity of platinum.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Feasibility Studies; Female; Humans; Infusions, Intra-Arterial; Middle Aged; Neoplasm Staging; Platinum; Uterine Neoplasms | 2001 |
Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Cyclophosphamide; Doxorubicin; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Galactitol; Humans; Lung Neoplasms; Male; Middle Aged; Platinum; Sugar Alcohols | 1977 |
Phase I trial of a cisplatin-albumin complex for the treatment of cancer of the head and neck.
Topics: Carcinoma, Squamous Cell; Cisplatin; Drug Compounding; Drug Evaluation; Head and Neck Neoplasms; Humans; Platinum; Serum Albumin | 1992 |
Effects of sodium thiosulfate in combination therapy of cis-dichlorodiammineplatinum and vindesine.
Topics: Adenocarcinoma; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Humans; Kidney; Lung Neoplasms; Platinum; Random Allocation; Thiosulfates; Time Factors; Vindesine | 1989 |
Prospective randomized trial of high-dose cisplatin and fluorouracil infusion with or without sodium diethyldithiocarbamate in recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Ditiocarb; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Kidney; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Prospective Studies; Random Allocation | 1988 |
Comparative study of intravenous and intraarterial cis-platinum on intratumoral platinum concentration in carcinoma of the cervix.
Topics: Adult; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Injections, Intra-Arterial; Injections, Intravenous; Middle Aged; Platinum; Uterine Cervical Neoplasms | 1989 |
A randomized study comparing platinum, doxorubicin, and VP-16 with platinum, 4'-epidoxorubicin, and VP-16 in patients with non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Doxorubicin; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Platinum; Podophyllotoxin; Random Allocation | 1987 |
75 other study(ies) available for platinum and Carcinoma, Epidermoid
Article | Year |
---|---|
Neoadjuvant chemotherapy with liposomal paclitaxel plus platinum for locally advanced esophageal squamous cell cancer: Results from a retrospective study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Epithelial Cells; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Platinum; Retrospective Studies | 2022 |
Sintilimab with chemotherapy as first-line treatment for locally advanced or metastatic squamous non-small-cell lung cancer: a real-world data study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Gemcitabine; Humans; Lung Neoplasms; Paclitaxel; Platinum; Prospective Studies; Retrospective Studies | 2023 |
Comparative survival analysis of platinum-based adjuvant chemotherapy for early-stage squamous cell carcinoma and adenocarcinoma of the lung.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Humans; Lung; Lung Neoplasms; Neoplasm Staging; Platinum; Survival Analysis | 2022 |
Advanced thymic lymphoepithelioma-like carcinoma with bone marrow metastases treated by immunotherapy combined with antiangiogenesis therapy: a case report.
Topics: Bone Marrow Neoplasms; Bone Neoplasms; Carcinoma, Squamous Cell; Humans; Immunotherapy; Platinum | 2022 |
Role of APOA1 in the resistance to platinum-based chemotherapy in squamous cervical cancer.
Topics: Apolipoprotein A-I; Breast Neoplasms; Carcinoma, Squamous Cell; Female; Humans; Phosphatidylinositol 3-Kinases; Platinum; Uterine Cervical Neoplasms | 2022 |
Tumor response and survival outcomes of salvage concurrent chemoradiotherapy with three-dimensional conformal radiotherapy and 5-fluorouracil/platinum-based chemotherapy for postoperative locoregional recurrence of esophageal squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorouracil; Humans; Neoplasm Recurrence, Local; Platinum; Radiotherapy, Conformal; Retrospective Studies | 2022 |
Combined taxane, platinum, and cetuximab as a first-line treatment for recurrent/metastatic head and neck squamous cell carcinoma: Retrospective study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Platinum; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taxoids | 2022 |
Nivolumab for Platinum-refractory and -sensitive Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Nivolumab; Platinum; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
PD-1 inhibition plus platinum-based chemotherapy (PBC) or PBC alone in the first-line treatment of locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma.
Topics: Carcinoma, Squamous Cell; Humans; Immune Checkpoint Inhibitors; Lung Neoplasms; Platinum; Programmed Cell Death 1 Receptor; Retrospective Studies | 2022 |
Hybrid nano-architectures loaded with metal complexes for the co-chemotherapy of head and neck carcinomas.
Topics: Carcinoma, Squamous Cell; Cisplatin; Coordination Complexes; Head and Neck Neoplasms; Humans; Platinum; Squamous Cell Carcinoma of Head and Neck | 2023 |
Hypoxia alleviating platinum(IV)/chlorin e6-based combination chemotherapeutic-photodynamic nanomedicine for oropharyngeal carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Chlorophyllides; Head and Neck Neoplasms; Hypoxia; Mice; Mouth Neoplasms; Nanomedicine; Nanoparticles; Oxygen; Photochemotherapy; Photosensitizing Agents; Platinum; Porphyrins; Squamous Cell Carcinoma of Head and Neck | 2023 |
Comparison of Efficacy and Safety of Platinum-Based Chemotherapy as First-Line Therapy between B3 Thymoma and Thymic Carcinoma.
Topics: Carcinoma, Squamous Cell; Humans; Platinum; Retrospective Studies; Thymoma; Thymus Neoplasms | 2022 |
The effect of opioids on the efficacy of immunotherapy in recurrent/metastatic squamous cell carcinoma of the head and neck.
Topics: Analgesics, Opioid; Antibodies, Monoclonal; Carcinoma, Squamous Cell; CD8-Positive T-Lymphocytes; Female; Head and Neck Neoplasms; Humans; Immunotherapy; Male; Neoplasm Recurrence, Local; Platinum; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tumor Microenvironment | 2023 |
Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: The Phase 2 CheckMate 714 Randomized Clinical Trial.
Topics: Carcinoma, Squamous Cell; Double-Blind Method; Head and Neck Neoplasms; Humans; Immunotherapy; Ipilimumab; Male; Middle Aged; Neoplasm Recurrence, Local; Nivolumab; Platinum; Squamous Cell Carcinoma of Head and Neck | 2023 |
[Primary squamous cell carcinoma of the prostate: Clinical features and therapeutic strategies].
Topics: Carcinoma, Squamous Cell; Humans; Male; Platinum; Prognosis; Prostate | 2022 |
Homologous recombination in lung cancer, germline and somatic mutations, clinical and phenotype characterization.
Topics: Adenocarcinoma of Lung; Aged; Biomarkers, Tumor; BRCA1 Protein; BRCA2 Protein; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Fanconi Anemia Complementation Group N Protein; Female; Follow-Up Studies; Germ-Line Mutation; Homologous Recombination; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Platinum; Prognosis; Retrospective Studies; Survival Rate | 2019 |
Real-World Effectiveness of Nivolumab Monotherapy After Prior Systemic Therapy in Advanced Non-Small-Cell Lung Cancer in the United States.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Nivolumab; Platinum; Prognosis; Retrospective Studies; Survival Rate; United States | 2021 |
Carcinostatic effects of alkanoyl ascorbate plus platinum nano-colloid and stabilization of the esterolytically resultant ascorbate by hydrogen.
Topics: Antineoplastic Agents; Ascorbic Acid; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colloids; Esophageal Neoplasms; Humans; Hydrogen; Nanocomposites; Platinum; Water | 2021 |
Topics: Adult; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antigens, Surface; Antineoplastic Agents; Antioxidants; Antiviral Agents; Aporphines; Atherosclerosis; Benzoyl Peroxide; beta Catenin; Biofilms; Biomarkers; Brain; Cannabis; Carcinoma, Squamous Cell; Case-Control Studies; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Child; China; Chlorides; Chlorophyll; Cholesterol, LDL; Coinfection; Corylus; Cross-Sectional Studies; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Developmental Disabilities; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Electroencephalography; Environmental Exposure; Enzyme Inhibitors; Epilepsy, Generalized; Ethnicity; Female; Fertilization in Vitro; Fluorescent Dyes; Follow-Up Studies; Forecasting; Glutamate Carboxypeptidase II; Glycine; Half-Life; Head and Neck Neoplasms; Health Communication; Heart Ventricles; Hepacivirus; Hepatitis C; Heterosexuality; HIV Infections; Humans; Hypercholesterolemia; Immunoassay; Inhalation Exposure; Isocitrate Dehydrogenase; Laryngeal Neoplasms; Ligands; Light; Lipopolysaccharide Receptors; Liver Cirrhosis; Lung; Lung Neoplasms; Magnetic Resonance Imaging, Cine; Male; Maternal Age; Mechanical Phenomena; Mice; Mice, Nude; Mice, SCID; Microglia; MicroRNAs; Microscopy, Fluorescence; Microsomes, Liver; Middle Aged; Minority Groups; Mitochondrial Membrane Transport Proteins; Models, Biological; Molecular Structure; Molecular Weight; Monte Carlo Method; Muscle Hypotonia; Mutagenesis, Site-Directed; Mutation, Missense; Natriuretic Peptide, Brain; Neoplasms; Nickel; Nitric Oxide; Optical Imaging; Oxides; Particle Size; Particulate Matter; PCSK9 Inhibitors; Peptide Fragments; Phenotype; Photochemotherapy; Photosensitizing Agents; Phytochemicals; Piper; Placenta Growth Factor; Plant Extracts; Plant Leaves; Plant Stems; Platinum; Point-of-Care Testing; Population Surveillance; Postpartum Period; Pregnancy; Pregnancy, Twin; Prevalence; Prospective Studies; Prostatic Neoplasms; Pseudomonas aeruginosa; Pyridines; Pyridones; Racial Groups; Rats; Respiratory Physiological Phenomena; Retrospective Studies; Risk Factors; RNA, Long Noncoding; Semiconductors; Sexual and Gender Minorities; Sexual Behavior; Social Media; Sodium; Solubility; Stereoisomerism; Stochastic Processes; Structure-Activity Relationship; Substance-Related Disorders; Sustained Virologic Response; Sweat; Temperature; Time Factors; Tissue Distribution; Titanium; Transplantation, Heterologous; Tumor Cells, Cultured; Tungsten; Tyramine; United States; Up-Regulation; Ventricular Dysfunction, Left; Ventricular Function, Left; Veterans; Xenograft Model Antitumor Assays; Young Adult | 2021 |
Neoadjuvant treatment of pembrolizumab plus platinum-doublet chemotherapy in stage IIIA squamous cell carcinoma of the lung: a case report.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Platinum | 2021 |
Long-term outcomes of postoperative taxane/platinum chemotherapy for early stage cervical cancer: a retrospective study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Platinum; Postoperative Care; Prognosis; Retrospective Studies; Survival Rate; Taxoids; Uterine Cervical Neoplasms; Young Adult | 2018 |
Bafilomycin A1 increases the sensitivity of tongue squamous cell carcinoma cells to cisplatin by inhibiting the lysosomal uptake of platinum ions but not autophagy.
Topics: Autophagy; Autophagy-Related Protein 5; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Gene Knockout Techniques; Humans; Lysosomes; Macrolides; Platinum; Proto-Oncogene Proteins c-abl; Tongue Neoplasms | 2018 |
Antitumor effect of a Pt-loaded nanocomposite based on graphene quantum dots combats hypoxia-induced chemoresistance of oral squamous cell carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle Checkpoints; Cell Hypoxia; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cisplatin; Drug Delivery Systems; Drug Resistance, Neoplasm; Graphite; Humans; Hydrogen-Ion Concentration; Male; Mice, Inbred BALB C; Mouth Neoplasms; Nanocomposites; Platinum; Quantum Dots; Tumor Microenvironment | 2018 |
Nimotuzumab combined with chemotherapy as first-line treatment for advanced lung squamous cell carcinoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Therapy; ErbB Receptors; Female; Gene Dosage; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Middle Aged; Platinum; Retrospective Studies; Survival Analysis; Treatment Outcome | 2018 |
Anticancer effect of novel platinum nanocomposite beads on oral squamous cell carcinoma cells.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Humans; Male; Mice; Mice, Nude; Mouth Neoplasms; Nanocomposites; Platinum; Xenograft Model Antitumor Assays | 2019 |
[The Concept of Platinum-Resistance and Treatment Strategies in Head and Neck Cancer].
Topics: Carcinoma, Squamous Cell; Cetuximab; Drug Resistance, Neoplasm; Head and Neck Neoplasms; Humans; Platinum | 2019 |
Safety and Effectiveness of Chemotherapy for Metastatic Esophageal Cancer in a Community Hospital in Brazil.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brazil; Carcinoma, Squamous Cell; Esophageal Neoplasms; Hospitals, Community; Humans; Irinotecan; Middle Aged; Neoplasms, Multiple Primary; Paclitaxel; Platinum; Retrospective Studies; Survival Analysis; Treatment Outcome | 2019 |
DNA-bound platinum is the major determinant of cisplatin sensitivity in head and neck squamous carcinoma cells.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cisplatin; DNA Adducts; DNA, Neoplasm; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Head and Neck Neoplasms; Humans; Inhibitory Concentration 50; Mutation; Platinum; RNA, Messenger; Squamous Cell Carcinoma of Head and Neck; Statistics, Nonparametric; Tumor Suppressor Protein p53 | 2013 |
Novel association between CD74 polymorphisms and hematologic toxicity in patients with NSCLC after platinum-based chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antigens, Differentiation, B-Lymphocyte; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Adenosquamous; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; DNA, Neoplasm; Female; Follow-Up Studies; Gastrointestinal Diseases; Genotype; Haplotypes; Hematologic Diseases; Histocompatibility Antigens Class II; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Platinum; Polymorphism, Single Nucleotide; Prognosis | 2014 |
Concurrent cetuximab versus platinum-based chemoradiation for the definitive treatment of locoregionally advanced head and neck cancer.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cohort Studies; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Platinum; Prognosis; Retrospective Studies; Risk Assessment; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Treatment Outcome | 2015 |
Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a retrospective study in a single comprehensive European cancer institution.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Disease-Free Survival; Europe; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Grading; Platinum; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2014 |
Homozygous GNAS 393C-allele carriers with locally advanced esophageal cancer fail to benefit from platinum-based preoperative chemoradiotherapy.
Topics: Adenocarcinoma; Biomarkers, Tumor; Carcinoma, Squamous Cell; Chemoradiotherapy; Chromogranins; Esophageal Neoplasms; Female; Follow-Up Studies; Genotype; GTP-Binding Protein alpha Subunits, Gs; Homozygote; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Platinum; Polymorphism, Single Nucleotide; Prognosis; Survival Rate | 2014 |
PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Carrier Proteins; Deoxycytidine; Docetaxel; Female; Follow-Up Studies; Gemcitabine; Glutamates; Guanine; Humans; Immunoenzyme Techniques; Lung Neoplasms; Lymphatic Metastasis; Male; Membrane Proteins; Middle Aged; Neoplasm Staging; Pemetrexed; Platinum; Prognosis; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Taxoids; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2014 |
A retrospective study of docetaxel or paclitaxel in patients with advanced or recurrent esophageal squamous cell carcinoma who previously received fluoropyrimidine- and platinum-based chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Platinum; Prognosis; Pyrimidines; Retrospective Studies; Survival Rate; Taxoids; Treatment Outcome | 2014 |
Comparison of acute toxicities associated with cetuximab-based bioradiotherapy and platinum-based chemoradiotherapy for head and neck squamous cell carcinomas: A single-institution retrospective study in Japan.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Female; Head and Neck Neoplasms; Humans; Incidence; Japan; Male; Middle Aged; Mucositis; Neoplasm Staging; Platinum; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2015 |
Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cyclooxygenase 2; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Platinum; Prognosis; Retrospective Studies; Survival Rate; Tegafur | 2015 |
Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Follow-Up Studies; France; Humans; Incidence; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Platinum; Prognosis; Retrospective Studies; Survival Rate | 2015 |
Primary combined neuroendocrine carcinoma (small-cell type) and squamous cell carcinoma of the colon.
Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Colon; Colonic Neoplasms; Etoposide; Fatal Outcome; Humans; Male; Platinum; Point Mutation; Proto-Oncogene Proteins p21(ras); Tomography, X-Ray Computed | 2016 |
Copper Transporter-CTR1 Expression and Pathological Outcomes in Platinum-treated Muscle-invasive Bladder Cancer Patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cation Transport Proteins; Copper Transporter 1; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Male; Middle Aged; Muscle Neoplasms; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Platinum; Prognosis; Urinary Bladder Neoplasms | 2016 |
Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Line, Tumor; Cetuximab; Drug Resistance, Neoplasm; ErbB Receptors; Fluorouracil; GTP Phosphohydrolases; Head and Neck Neoplasms; High-Throughput Nucleotide Sequencing; Humans; Liquid Biopsy; Membrane Proteins; Mutation; Platinum; Proto-Oncogene Proteins p21(ras); ras Proteins | 2016 |
Genetic variants of DNA repair genes predict the survival of patients with esophageal squamous cell cancer receiving platinum-based adjuvant chemotherapy.
Topics: Asian People; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Demography; Disease-Free Survival; DNA Repair; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Genetic Association Studies; Humans; Kaplan-Meier Estimate; Multivariate Analysis; Platinum; Polymorphism, Single Nucleotide; Prognosis; ROC Curve | 2016 |
Folate Receptor Alpha Expression in Platinum Resistant/Refractory Ovarian Carcinomas and Primary Endocervical Adenocarcinomas.
Topics: Adenocarcinoma; Adolescent; Adult; Carcinoma, Squamous Cell; Drug Resistance, Neoplasm; Female; Folate Receptor 1; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Proteins; Ovarian Neoplasms; Platinum; Uterine Cervical Neoplasms | 2018 |
Effect of BRCA1 haplotype on survival of non-small-cell lung cancer patients treated with platinum-based chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Gene Frequency; Genotype; Haplotypes; Humans; Lung Neoplasms; Male; Middle Aged; Platinum; Polymorphism, Genetic; Prognosis; Ubiquitin-Protein Ligases | 2008 |
Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Carcinoma, Adenosquamous; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Platinum; Prognosis; Retrospective Studies; Survival Rate | 2009 |
Neoadjuvant chemotherapy with paclitaxel plus platinum followed by radical surgery in early cervical cancer during pregnancy: three case reports.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cesarean Section; Female; Humans; Hysterectomy; Magnetic Resonance Imaging; Neoadjuvant Therapy; Paclitaxel; Platinum; Pregnancy; Pregnancy Complications, Neoplastic; Uterine Cervical Neoplasms | 2010 |
Cellular pharmacokinetic/pharmacodynamic relationship of platinum cytostatics in head and neck squamous cell carcinoma evaluated by liquid chromatography coupled to tandem mass spectrometry.
Topics: Aged; Carcinoma, Squamous Cell; Cell Line, Tumor; Chromatography, Liquid; Cytostatic Agents; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multidrug Resistance-Associated Protein 2; Platinum; Reproducibility of Results; Squamous Cell Carcinoma of Head and Neck; Tandem Mass Spectrometry | 2012 |
Outcomes after adjuvant platinum-based chemotherapy in elderly NSCLC patients with T4 disease.
Topics: Adenocarcinoma; Aged; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Platinum; Prognosis; SEER Program; Survival Rate | 2013 |
Computed tomography RECIST assessment of histopathologic response and prediction of survival in patients with resectable non-small-cell lung cancer after neoadjuvant chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Platinum; Prognosis; Retrospective Studies; Survival Rate; Taxoids; Tomography, X-Ray Computed | 2013 |
Single-agent docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN).
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Docetaxel; Drug Tolerance; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Retrospective Studies; Taxoids; Treatment Outcome | 2007 |
The role of chemotherapy for advanced carcinoma of the supraglottic and glottic larynx.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Glottis; Humans; Laryngeal Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Palliative Care; Platinum | 1984 |
Tumor concentration of platinum in patients with head and neck cancer.
Topics: Animals; Carcinoma, Squamous Cell; Cisplatin; Dogs; Dose-Response Relationship, Drug; Drug Resistance; Head and Neck Neoplasms; Humans; In Vitro Techniques; Platinum | 1983 |
Pharmacokinetics of free platinum species following rapid, 3-hr and 24-hr infusions of cis-diamminedichloroplatinum (II) and its therapeutic implications.
Topics: Aged; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Infusions, Parenteral; Kinetics; Male; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Platinum; Tongue Neoplasms | 1982 |
[Pharmacokinetics of cis-dichlorodiammineplatinum (II)].
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Cisplatin; Head and Neck Neoplasms; Humans; Kinetics; Platinum; Spectrophotometry, Atomic | 1982 |
[Pharmacokinetic of platin in plasma and urine of man under 1-, 8-, and 24 h-infusion with cis-dichlorodiamine-platin (II) (cis-DDP) (author's transl)].
Topics: Adult; Carcinoma, Squamous Cell; Cisplatin; Female; Head and Neck Neoplasms; Humans; Infusions, Parenteral; Kinetics; Lung Neoplasms; Lymphoma; Male; Middle Aged; Ovarian Neoplasms; Platinum; Testicular Neoplasms | 1982 |
Eradication and palliation of squamous cell carcinoma of the esophagus with chemotherapy, radiotherapy, and surgical therapy.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagus; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycins; Platinum | 1981 |
[A study of intra-arterial infusion with carboplatin (CBDCA) for 2 patients with maxillary gingival cancer].
Topics: Aged; Carboplatin; Carcinoma, Squamous Cell; Female; Gingival Neoplasms; Humans; Infusions, Intra-Arterial; Male; Maxilla; Platinum | 1994 |
[Distribution of platinum in the female genital tract after intraarterial carboplatin infusion during the operation of uterine cervical cancer].
Topics: Adenocarcinoma; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Genitalia, Female; Humans; Infusions, Intra-Arterial; Intraoperative Care; Lymph Nodes; Platinum; Uterine Cervical Neoplasms | 1994 |
Determination of platinum in urine, ultrafiltrate, and whole plasma by isotope dilution gas chromatography-mass spectrometry compared to electrothermal atomic absorption spectrometry.
Topics: Carcinoma, Squamous Cell; Cisplatin; Evaluation Studies as Topic; Gas Chromatography-Mass Spectrometry; Humans; Laryngeal Neoplasms; Male; Middle Aged; Platinum; Spectrophotometry, Atomic | 1993 |
A topographic study on the distribution of cisplatin in xenografted tumors on nude mice.
Topics: Animals; Carcinoma, Squamous Cell; Cisplatin; DNA Adducts; Mice; Mice, Inbred BALB C; Mice, Nude; Platinum; Transplantation, Heterologous; Tumor Cells, Cultured | 1996 |
Hyperthermia enhances the cytotoxicity and platinum-DNA adduct formation of lobaplatin and oxaliplatin in cultured SW 1573 cells.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Cyclobutanes; DNA Adducts; DNA, Neoplasm; Humans; Hyperthermia, Induced; Lung Neoplasms; Organoplatinum Compounds; Oxaliplatin; Platinum; Tumor Cells, Cultured | 1997 |
Relationship between the parameters cellular differentiation, doubling time and platinum accumulation and cisplatin sensitivity in a panel of head and neck cancer cell lines.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Differentiation; Cell Division; Cell Line; Cisplatin; DNA, Neoplasm; Female; Head and Neck Neoplasms; Humans; Kinetics; Male; Middle Aged; Platinum; Time Factors; Tumor Cells, Cultured | 1997 |
Effect of cisplatin exposure on platinum accumulation and growth inhibition in human neoplastic and normal squamous epithelial cells of the mucosa of the upper-aerodigestive tract.
Topics: Adult; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Division; Cisplatin; Epithelial Cells; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Platinum; Tumor Cells, Cultured; Uvula | 1999 |
[Pharmacologic markers predictive of neutropenia chemically induced by cisplatin (CDDP)].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Choriocarcinoma; Cisplatin; DNA Adducts; Drug Monitoring; Female; Fluorouracil; Humans; Lymphocytes; Male; Middle Aged; Neoplasms; Neutropenia; Ovarian Neoplasms; Platinum; Predictive Value of Tests; Saliva | 1999 |
Antitumor effect of radioactive cisplatin (191Pt) on nude mice.
Topics: Animals; Antineoplastic Agents; Body Weight; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Combinations; Drug Screening Assays, Antitumor; Female; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Platinum; Radiation-Sensitizing Agents; Radioisotopes; Transplantation, Heterologous | 2001 |
[Tissue platinum distribution and the effect following intra-arterial injection of cisplatin to metastatic liver cancer--a case report].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Fluorouracil; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Platinum; Tissue Distribution | 2001 |
Chemotherapy alone with curative intent in patients with invasive squamous cell carcinoma of the pharyngolarynx classified as T1-T4N0M0 complete clinical responders.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug Therapy, Combination; Female; Fluorouracil; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasms, Second Primary; Pharyngeal Neoplasms; Platinum; Salvage Therapy | 2001 |
Reduced drug accumulation in a newly established human lung squamous-carcinoma cell line resistant to cis-diamminedichloroplatinum(II).
Topics: Carcinoma, Squamous Cell; Cell Division; Cell Line; Cisplatin; Drug Resistance; Humans; Lung Neoplasms; Platinum; Tetrazolium Salts; Thiazoles | 1992 |
Analysis of tissue platinum distribution in patients with cancer of the oesophagus.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Esophagus; Humans; Male; Middle Aged; Platinum | 1991 |
Characteristics of five human tumor cell lines and sublines resistant to cis-diamminedichloroplatinum(II).
Topics: Adenocarcinoma; Breast Neoplasms; Carboplatin; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Survival; Cisplatin; DNA; Drug Resistance; Glutathione Transferase; Humans; Lung Neoplasms; Melanoma; Neoplasms; Organoplatinum Compounds; Platinum; Sulfhydryl Compounds; Tumor Cells, Cultured | 1991 |
Disposition and tumour concentrations of platinum in hypoalbuminaemic patients after treatment with cisplatin for cancer of the head and neck.
Topics: Adult; Aged; Biopsy; Carcinoma, Squamous Cell; Cisplatin; Dose-Response Relationship, Drug; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Platinum; Serum Albumin | 1991 |
Preliminary results of preoperative chemotherapy with a combination of platinum-bleomycin administered in 5-day cycles in carcinoma of the bronchus.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchial Neoplasms; Carcinoma, Squamous Cell; Combined Modality Therapy; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Platinum; Postoperative Complications; Vindesine | 1986 |
[Balloon occluded arterial infusion (BOAI) therapy in patients with progressive cervical carcinoma].
Topics: Aclarubicin; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Catheterization; Cisplatin; Embolization, Therapeutic; Evaluation Studies as Topic; Female; Humans; Iliac Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Infusions, Parenteral; Middle Aged; Platinum; Remission Induction; Tissue Distribution; Uterine Cervical Neoplasms | 1989 |
Platinum-dye complexes inhibit repair of potentially lethal damage following bleomycin treatment.
Topics: Bleomycin; Carcinoma, Squamous Cell; Cell Line; Cell Survival; Cisplatin; Coloring Agents; DNA Repair; DNA, Neoplasm; Humans; Platinum; Tongue Neoplasms | 1989 |
Intracellular distribution of a platinum-rhodamine 123 complex in cis-platinum sensitive and resistant human squamous carcinoma cell lines.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line; Cisplatin; Drug Resistance; Fluorescence; Humans; Organoplatinum Compounds; Platinum; Radiation-Sensitizing Agents; Rhodamine 123; Rhodamines; Xanthenes | 1986 |
Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II).
Topics: Biological Transport; Cadmium; Carboplatin; Carcinoma, Squamous Cell; Cell Line; Cell Membrane; Cisplatin; Drug Resistance; Glutathione Transferase; Humans; Metallothionein; Organoplatinum Compounds; Platinum; Structure-Activity Relationship; Sulfhydryl Compounds | 1987 |